HOME >> MEDICINE >> NEWS
A drug's brand name skews patient treatment choices

The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.

The unexpected finding regarding the strong influence that drug names have on treatment choices emerged from a study undertaken by Dr. Anne Holbrook and McMaster colleagues who wanted to see if certain features of a decision aid i.e., format and graphic presentation of data on benefits and harms of treatment options make a difference. They designed a decision aid for anticoagulant drug therapy for atrial fibrillation in 3 formats (decision board, decision booklet with audiotape, or interactive computer program) with 2 types of data presentation (pie graph or pictogram). The treatment options were identified initially as "treatment A" (warfarin), "treatment B" (acetylsalicylic acid) and "treatment C" (no treatment). The authors found that the participants comprehension of the condition and treatment options improved significantly with the decision aid, regardless of the format or graphic presentation of data. Virtually all (96%) of the participants felt that the decision aid helped them make their treatment choice.

But unexpectedly, they also discovered that after participants were shown the true treatment names, 36% changed their initial choice (including 46% of those who initially chose warfarin and 78% of those who initially chose no treatment), even though the risks and benefits of each treatment were clearly laid out in the decision aid.

In a related commentary, Dr. Annette O'Connor notes that many common medical decisions exist in a "grey zone," where the best choice differs depending on how patients weigh the benefits and risks of each treatment option. She discusses how patient decision aids differ from educational aids and how they help patients and express their personal values.


'"/>

Contact: Dr. Anne Holbrook
905-525-9140 x22169
Canadian Medical Association Journal
21-May-2007


Page: 1

Related medicine news :

1. Chemical maps hint at drugs effects on schizophrenia
2. Study to test drugs potential to preserve insulin production in newly diagnosed type 1 diabetics
3. Anti-inflammatory drugs potentially deadly side effect found to be rare
4. Trial demonstrates new drugs effectiveness against psoriasis
5. Young childrens taste preferences may be influenced by fast-food branding
6. MRI shows brains respond better to name brands
7. Mega-brands have mega influence on dietary behavior
8. Alcohol-branded merchandise associated with early teen drinking
9. Brain-scanning technology reveals how we process brands and products
10. Where your brain wires itself to like (name your favorite brand)
11. Health benefits of a Christmas brandy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... ... body strength, which often leads to a host of health issues, including urinary ... American Geriatrics Society discovered that good overall muscle strength in older women, ...
(Date:2/27/2017)... RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... disorder, but concern for women who become dependent on opioid painkillers has fallen short. ... female patients, compared to a 237% increase in fatal overdoses in male populations.(1) , ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... overview on laser diffraction analysis as a tool to characterize particle size distributions ... potential to obtain improved results and novel scientific findings. It describes methods of ...
(Date:2/27/2017)... Vancouver, BC (PRWEB) , ... February 27, 2017 ... ... top drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at ... (RMT) to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  In conjunction with DURECT Corporation,s (Nasdaq: ... you are invited to listen to a conference call ... Tuesday, March 14, 2017 at 4:30 pm Eastern Time ... webcast of the presentation will be available by accessing ... Relations."  If you are unable to participate during the ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan Monteverde ... Associates PC , a boutique securities firm headquartered at ... City , announces that a class action lawsuit ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" ... Company,s securities between July 23, 2015 and December 30, 2016, ...
(Date:2/24/2017)... YORK , Feb. 23, 2017 Report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. ... Market data and analytics are derived from primary and secondary ...
Breaking Medicine Technology:
Cached News: